# Joseph L. Lillo, D.O., Phoenix, AZ – FDA Inspections

Source: https://www.keypedia.com/companies/joseph-l-lillo-do/1ea0d267-f3a4-4b8f-9611-61ba95abc6b1

> Inspection records and compliance data for Joseph L. Lillo, D.O. in Phoenix, Arizona. 5 FDA inspections on record, 2 Form 483s, last inspected March 22, 2021.

---

## Details

- Name: Joseph L. Lillo, D.O.
- FEI Number: 3010626491
- Address Line 1: 4520 E Indian School Rd
- City: Phoenix
- State: Arizona
- Zip Code: 85018
- Country Name: United States
- Address: 4520 E Indian School Rd, Phoenix, Arizona 85018, United States
- Country: United States

## Inspection summary

- FDA inspections: 5 (February 26, 2014 to March 22, 2021)
- Classifications: NAI 2, VAI 3
- Form 483s: 2
- Warning letters: 0
- Most cited issues: FD-1572, protocol compliance (2); Case history records- inadequate or inadequate (1)

## FDA inspections

- [March 22, 2021](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/5a802237-2c7a-4b96-a384-8d98800b915f) — Voluntary Action Indicated (VAI), Human Drugs, Bioresearch Monitoring
- December 9, 2019 — No Action Indicated (NAI), Human Drugs, Bioresearch Monitoring
- [April 17, 2017](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/1df67e89-7f5b-42de-9273-2767b9fe60d6) — Voluntary Action Indicated (VAI), Human Drugs, Bioresearch Monitoring, Form 483 issued
- [April 12, 2017](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/46c8c5aa-ab63-47bd-8955-02f814c16650) — Voluntary Action Indicated (VAI), Human Drugs, Bioresearch Monitoring, Form 483 issued
- February 26, 2014 — No Action Indicated (NAI), Human Drugs, Bioresearch Monitoring

## Form 483s (2)

- [483 - Joseph L. Lillo, D.O. - 2021-03-22](https://www.keypedia.com/records/483/joseph-l-lillo-do/d65fcd27-e80d-49f3-a8d7-c82d6fa4141f) — March 22, 2021
- [483 - Joseph L. Lillo, D.O. - 2019-12-09](https://www.keypedia.com/records/483/joseph-l-lillo-do/3cb3f785-3fa7-4e4d-b237-62fcd109b8b1) — December 9, 2019

## Related Documents

- [483 - Joseph L. Lillo, D.O. - 2021-03-22](https://www.keypedia.com/records/483/joseph-l-lillo-do/d65fcd27-e80d-49f3-a8d7-c82d6fa4141f) — source: FDA, date: March 22, 2021
- [FDA Inspection 1136939 - Joseph L. Lillo, D.O. - 2021-03-22](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/5a802237-2c7a-4b96-a384-8d98800b915f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2021
- [483 - Joseph L. Lillo, D.O. - 2019-12-09](https://www.keypedia.com/records/483/joseph-l-lillo-do/3cb3f785-3fa7-4e4d-b237-62fcd109b8b1) — source: FDA, date: December 9, 2019
- FDA Inspection 1112185 - Joseph L. Lillo, D.O. - 2019-12-09 — classification: No Action Indicated (NAI), source: FDA, date: December 9, 2019
- [FDA Inspection 1009887 - Joseph L. Lillo, D.O. - 2017-04-17](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/1df67e89-7f5b-42de-9273-2767b9fe60d6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2017
- [FDA Inspection 1009886 - Joseph L. Lillo, D.O. - 2017-04-12](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/46c8c5aa-ab63-47bd-8955-02f814c16650) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2017
- FDA Inspection 866757 - Joseph L. Lillo, D.O. - 2014-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2014

## Related Companies

- [Nationwide Laboratories, LLC](https://www.keypedia.com/companies/nationwide-laboratories-llc/e5dccf31-f7a6-4a51-9f59-7e2929127933)
- [Andapharm, LLC](https://www.keypedia.com/companies/andapharm-llc/62711f7a-0996-4623-93e4-87351349e6c9)
- [Corden Pharma Boulder, Inc.](https://www.keypedia.com/companies/corden-pharma-boulder-inc/ac780a14-1ead-48c8-8376-cb62f7114aec)
- [West Coast Cosmetics Inc](https://www.keypedia.com/companies/west-coast-cosmetics-inc/6d3129c0-b7de-4b7c-b7ee-f115624a9b8e)
- [Shishuka Malhotra MD](https://www.keypedia.com/companies/shishuka-malhotra-md/01b66b3a-180c-4784-8210-0d1454be1832)
- [Mirum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d)
- [Hagop M. Kantarjian, M.D.](https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9)
- [NuSil Technology LLC](https://www.keypedia.com/companies/nusil-technology-llc/ef176ca7-d941-4939-89a4-be78633f5cb4)
- [John D. Gabriel, MD](https://www.keypedia.com/companies/john-d-gabriel-md/6c8dab33-f0fe-48ec-8b27-7c62dededa1f)
- [Rpk Pharmaceuticals Inc](https://www.keypedia.com/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michelle-j-hines/c8087e41-6b8a-4b9a-92ad-bba500ce6fee)
